Bitmine Immersion Technologies, Inc. is not an ETF but a U.S.-listed equity — a blockchain infrastructure and "Ethereum treasury" company that acquires and stakes Ethereum as its core asset. Sell-side coverage of BMNR is thin, and only two current, attributable price targets could be verified. Cantor Fitzgerald holds an Overweight rating with a $63.60 target (set September 10, 2026 and reaffirmed October 6, 2026), while B. Riley Financial rates the stock Buy with a $34.00 target (raised from $30.00 on September 22, 2026). Weiss Ratings, by contrast, carries a Sell (D-) rating without a published price target.
The arithmetic mean of the two numeric targets is $48.80, rounded to $49 for this analysis, with a low-to-high range of $34.00 to $63.60. That span — nearly a 2-to-1 difference — signals genuine disagreement. Cantor's higher figure reflects a stronger view of Ethereum's recovery and the value of Bitmine's token holdings, while B. Riley's lower target embeds a more conservative assumption about near-term crypto sentiment. Because coverage is so limited, this $49 figure is best understood as a directional marker rather than a broad consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With BMNR last trading around $22.40, reaching $49 would require an advance of roughly 119%, which is a very large move by any standard. The stock trades well below its 52-week high near $54–$55 and well above its 52-week low near $12.80, reflecting a violent repricing since Bitmine pivoted to Ethereum accumulation. A path toward the target would likely depend on a durable rebound in Ethereum's price, continued treasury accumulation toward the company's stated "5% of supply" goal, and renewed institutional inflows into digital assets. Without sustained Ethereum strength, the premium required to close that gap is difficult to justify on operating results alone, as the company remains unprofitable on a GAAP basis.
On the downside, the 52-week low near $12.80 is the most significant support level, with the $20 area acting as a psychological floor. On the upside, the $30 zone and B. Riley's $34 target mark the first resistance levels, while the $54–$55 region — the prior 52-week high — represents a major hurdle on any sustained move toward $49. The stock's 200-day moving average has hovered near $20–$21, and a late-September "golden cross" suggested an improving longer-term trend, though recent price action has remained choppy. From what I see, monitoring these levels closely helps frame realistic scenarios.
Analyst price targets typically reflect a roughly 12-month research horizon, though the two firms here do not publish identical timelines. Investors should watch Ethereum's spot price and staking yields, quarterly results and guidance (including the next earnings report), any changes to the share-buyback program, regulatory developments affecting digital assets, and further analyst target revisions. Because the stock is effectively a leveraged vehicle on Ethereum, macro conditions — including interest-rate decisions — matter nearly as much as company-specific news. I’m watching this closely as developments unfold.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a high-volatility name like BMNR, this kind of automated monitoring can help traders spot changing trends and manage positions more efficiently than manual chart review alone. Explore the signals to complement your own research.
The $49 target reflects the average of just two verified analyst price targets — $63.60 and $34.00 — rather than a broad consensus, and it sits roughly 119% above the latest price. Reaching it would require a sustained Ethereum recovery, successful execution of Bitmine's treasury and staking strategy, and a market willing to pay a premium to underlying holdings. Against that, the company's losses, share dilution, and a conflicting Sell rating from Weiss Ratings present meaningful obstacles. With coverage this thin and disagreement this wide, the target is best treated as a directional scenario, not a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
BMNR saw its Momentum Indicator move below the 0 level on October 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 126 similar instances where the indicator turned negative. In 123 of the 126 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for BMNR turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 65 similar instances when the indicator turned negative. In 60 of the 65 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
BMNR moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BMNR crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMNR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for BMNR entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMNR's RSI Indicator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 69 cases where BMNR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The 50-day moving average for BMNR moved above the 200-day moving average on September 29, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +11.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMNR advanced for three days, in 93 of 134 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
BMNR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. BMNR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.165) is normal, around the industry mean (3.517). P/E Ratio (-5.221) is within average values for comparable stocks, (8.810). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.002) settles around the average of (7.656) among similar stocks. BMNR's P/S Ratio (133.333) is slightly higher than the industry average of (16.763).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMNR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentBanksBrokers